FRI0244 Low Dose of Rituximab Is Effective for Maintenance of Clinical Remission or Low Disease Activity in Patients With Rheumatoid Arthritis
doi 10.1136/annrheumdis-2017-eular.4958
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism